News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,175 Results
Type
Article (2481)
Company Profile (39)
Press Release (37655)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14425)
Career Advice (78)
Deals (2159)
Drug Delivery (9)
Drug Development (4218)
Employer Resources (10)
FDA (604)
Job Trends (779)
News (20843)
Policy (1112)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (150)
Allergies (6)
Alliances (3561)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (17)
Approvals (605)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (489)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (144)
Cardiovascular disease (5)
Career advice (65)
Career pathing (1)
CAR-T (16)
Cell therapy (45)
Cervical cancer (2)
Clinical research (3274)
Collaboration (95)
Compensation (49)
COVID-19 (181)
CRISPR (7)
C-suite (30)
Cystic fibrosis (2)
Data (121)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (470)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4320)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6200)
Executive appointments (96)
FDA (660)
Featured Employer (3)
Funding (81)
Gene editing (14)
Gene therapy (19)
GLP-1 (62)
Government (152)
Healthcare (733)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (186)
Inflammatory bowel disease (12)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (1021)
IRA (7)
Job creations (292)
Job search strategy (63)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (223)
Liver cancer (5)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (506)
Medtech (506)
Mergers & acquisitions (1211)
Metabolic disorders (35)
Multiple sclerosis (8)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (92)
NextGen: Class of 2025 (363)
Non-profit (154)
Northern California (371)
Now hiring (4)
Obesity (17)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (6)
Peanut (1)
People (5779)
Pharmaceutical (5)
Phase I (1399)
Phase II (1652)
Phase III (867)
Pipeline (78)
Policy (12)
Postmarket research (32)
Preclinical (613)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (22)
Real estate (425)
Recruiting (5)
Regulatory (855)
Reports (6)
Research institute (146)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (367)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (501)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1801)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (10)
Last 7 days (55)
Last 30 days (239)
Last 365 days (2607)
2025 (811)
2024 (2684)
2023 (2964)
2022 (3994)
2021 (4254)
2020 (3634)
2019 (2167)
2018 (1658)
2017 (1900)
2016 (1699)
2015 (1949)
2014 (1450)
2013 (1252)
2012 (1454)
2011 (1383)
2010 (1235)
Location
Africa (43)
Alabama (1)
Arizona (16)
Asia (2061)
Australia (303)
California (863)
Canada (136)
China (40)
Colorado (20)
Connecticut (12)
Delaware (4)
Europe (4022)
Florida (46)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (7)
Kansas (12)
Maryland (26)
Massachusetts (316)
Michigan (8)
Minnesota (16)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (72)
New York (51)
North Carolina (90)
Northern California (371)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (55)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (367)
Tennessee (2)
Texas (72)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (52)
Wisconsin (6)
40,175 Results for "lumen bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials
Lumen Bioscience—a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced it was awarded $16.2 million by the U.S. Department of Defense to advance LMN-201 through late-stage trials.
October 17, 2023
·
3 min read
FDA
Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201
Lumen Bioscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for LMN-201, an investigational, orally delivered biologic drug to treat and prevent C. difficile infection (CDI).
May 17, 2023
·
4 min read
BioForest
Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress
Lumen Bioscience provided a review of the company’s 2022 growth, including progress in its clinical development programs, GMP manufacturing expansion, and funding.
January 5, 2023
·
5 min read
BioForest
Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses
Lumen Bioscience today announced a new $8.8 million project funded by the U.S. Department of Defense (DOD) to develop and test a prototype broad-spectrum, fast-acting intranasal powder for treatment and prevention of known and emerging viral respiratory infections.
May 11, 2023
·
2 min read
BioForest
Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria
Lumen Bioscience today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria.
October 4, 2022
·
2 min read
BioForest
Lumen Bioscience Announces Clinical Advancement of LMN-201 for C. difficile Infection
Lumen Bioscience today announced clinical development progress for LMN-201, an investigational orally delivered cocktail to treat and prevent C. difficile infection (CDI).
April 18, 2022
·
4 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Arizona Biosciences Set Record Highs in Research Funding, Show Increasing Competitiveness
April 23, 2025
·
3 min read
Press Releases
Chromatin Bioscience Signs Collaboration Agreement with Astellas
April 14, 2025
·
2 min read
1 of 4,018
Next
